These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice. Dheen ST; Rajkumar K; Murphy LJ Diabetologia; 1996 Nov; 39(11):1249-54. PubMed ID: 8932988 [TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441 [TBL] [Abstract][Full Text] [Related]
6. Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion. Ma YH; Landis C; Tchao N; Wang J; Rodd G; Hanahan D; Bourne HR; Grodsky GM Endocrinology; 1994 Jan; 134(1):42-7. PubMed ID: 7506212 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Guo Y; Lu Y; Houle D; Robertson K; Tang Z; Kopchick JJ; Liu YL; Liu JL Endocrinology; 2005 Jun; 146(6):2602-9. PubMed ID: 15731363 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. Hong J; Zhang G; Dong F; Rechler MM J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719 [TBL] [Abstract][Full Text] [Related]
14. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Zhou YP; Pena JC; Roe MW; Mittal A; Levisetti M; Baldwin AC; Pugh W; Ostrega D; Ahmed N; Bindokas VP; Philipson LH; Hanahan D; Thompson CB; Polonsky KS Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E340-51. PubMed ID: 10662719 [TBL] [Abstract][Full Text] [Related]